An investigation on behalf of investors of MedEquities Realty Trust, Inc. (NYSE: MRT) in connection with the proposed takeover was announced and NYSE: MRT stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 01/08/2019 -- The takeover of MedEquities Realty Trust, Inc. is under investigation.
Investors who purchased shares of MedEquities Realty Trust, Inc. (NYSE: MRT) and currently hold any of those NYSE: MRT shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of MedEquities Realty Trust, Inc. breached their fiduciary duties owed to NYSE: MRT investors in connection with the proposed acquisition.
Nashville, TN based MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. On January 2, 2019, Omega Healthcare Investors, Inc. (NYSE: OHI) and MedEquities Realty Trust, Inc. (NYSE: MRT) announced the execution of a merger agreement under which Omega will acquire all of the outstanding shares of MedEquities Realty Trust, Inc. (NYSE: MRT). Under the terms of the agreement, MedEquities Realty Trust, Inc. (NYSE: MRT) stockholders will receive a fixed exchange ratio of 0.235 Omega common shares plus $2.00 in cash for each share of MedEquities common stock held by them, which represents a value of $10.26 per MedEquities share based on the $35.15 closing price for Omega common stock on December 31, 2018. Separately, MedEquities will declare a special cash dividend of $0.21 per share payable to the holders of record of MedEquities common stock as of the end of trading on the New York Stock Exchange on the trading day immediately prior to the closing date of the transaction.
However, given that at least one analyst has set the high target price for NYSE: MRT shares at $12.00 per share, the investigation concerns whether the offer is unfair to NYSE: MRT stockholders. More specifically, the investigation concerns whether the MedEquities Realty Trust Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
On January 7, 2018, NYSE: MRT shares closed at $10.18 per share.
Those who are current investors in MedEquities Realty Trust, Inc. (NYSE: MRT) shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.